Sunshine Biopharma Inc.
13F holders, Q1 2026 (March 31)12holders −1
3new positions
4sold out
1famous investor
$1.04avg. 13F price*
At the end of Q1 2026, 12 institutions reported holding Sunshine Biopharma Inc. in their 13F filings, down 1 from Q4 2025. 3 opened new positions and 4 sold out. The largest holders were Citadel Advisors ($48K), Two Sigma Securities, LLC ($24K) and XTX Topco Ltd ($22K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Sunshine Biopharma Inc.
- CUSIP
- 867781700
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $38K |
| Exits | 4 | $29K |
All 13F filers, Q4 2025 → Q1 2026: 42,221 shares bought and 35,011 shares sold, net +7,210 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Citadel Advisors | 0.00% | Reduce -14.2% | 46,248 | $48K |
| Two Sigma Securities, LLC | 0.00% | New | 23,482 | $24K |
| XTX Topco Ltd | 0.00% | Add +32.8% | 21,457 | $22K |
| Morgan Stanley | 0.00% | No change | 14,634 | $15K |
| Commonwealth Equity Services, LLC | 0.00% | New | 13,437 | $14K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -62.2% | 1,834 | $2K |
| UBS Group AG | 0.00% | Reduce -41.1% | 1,103 | $1K |
| National Bank of Canada | 0.00% | Reduce -10.0% | 9 | $9 |
| Osaic Holdings, Inc. | 0.00% | Reduce -98.7% | 2 | $2 |
| CoreCap Advisors, LLC | 0.00% | New | 1 | $1 |
| Farther Finance Advisors, LLC | 0.00% | No change | 1 | $1 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is SUNSHINE BIOPHARMA INC's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. the manager owns.